-
Aβ25-35: From Neurotoxicity to Translation
2026-09-30
Amyloid Beta-peptide (25-35) provides a focused experimental window into amyloid-driven neuronal injury, oxidative stress, mitochondrial dysfunction, and microglial activation. This thought-leadership perspective connects Aβ25-35 assay design with the FLOT1–FOSL2–EphA2 inflammatory axis to help translational researchers build more decision-ready Alzheimer’s disease models.
-
Z-VAD-FMK for Apoptosis and Ferroptosis
2026-09-30
Z-VAD-FMK helps separate caspase-dependent apoptosis from alternative regulated cell-death programs in immune, cancer, and adipose-cell models. This workflow-focused guide shows how to use it as a mechanistic control without misclassifying ferroptosis as apoptosis.
-
GLP-1 Receptor Crosstalk in FRET cAMP Assays
2026-09-29
Chepurny and colleagues showed that glucagon can activate the GLP-1 receptor under experimental conditions, challenging the assumption that glucagon and GLP-1 receptor systems are fully selective. By combining high-throughput FRET measurements of cAMP with pharmacological controls, cellular validation, and molecular modeling, the study provides a framework for detecting receptor crosstalk and evaluating multi-receptor peptide designs.
-
Rottlerin Workflow for PKC Signaling and Viral Entry
2026-09-29
Rottlerin is a practical PKC inhibitor for connecting kinase signaling with cell proliferation inhibition, apoptosis induction, and pathogen-entry assays. This workflow shows how to build concentration-controlled experiments, interpret caspase-3 activation and PARP cleavage, and avoid mistaking general cytotoxicity for pathway-specific biology.
-
From Metabolic Stress to Cell-Cycle Evidence in CRC
2026-09-28
A mechanistic view of colorectal cancer research shows why metabolic disruption should be connected to direct cell-cycle measurements. Learn how DNA-content flow cytometry can help translational teams investigate cell-cycle arrest and apoptosis, interpret findings cautiously, and build stronger evidence with the Cell Cycle Assay Kit (Catalog No. K2263).
-
Solanesol Handling for Hydrophobic Research Workflows
2026-09-27
Solanesol is a hydrophobic polyisoprenoid alcohol for research workflows that need a defined compound compatible with DMSO preparation, not water- or ethanol-based stock solutions. This guide covers handling, controls, and practical limits for biochemical and cell-based studies; it does not establish biological efficacy or suitability for diagnostic or medical use.
-
DiscoveryProbe™ Metabolism-related Compound Library
2026-09-26
This 493-compound collection helps researchers screen metabolic targets and investigate pathway responses without assembling a compound set one molecule at a time. It is intended for in vitro and ex vivo research workflows, not for diagnostic, medical, clinical, or therapeutic use.
-
V5 Epitope Tag Peptide: From Sequence to Assay Design
2026-09-25
The V5 Epitope Tag Peptide offers a defined sequence for investigating antibody recognition and recombinant-protein detection. This guide connects epitope accessibility and antibody dissociation kinetics to practical choices in immunoblotting, immunoprecipitation, and advanced imaging.
-
N6-Methyl-dATP for DNA Fidelity Research
2026-09-25
Use N6-Methyl-dATP as a defined substrate probe to test how a methylated adenine nucleotide affects DNA polymerase activity and product formation. This practical workflow also clarifies what the AML LMO2/LDB1 study does—and does not—show about DNA replication and methylation research.
-
ASCH Proteins and ac4C Nucleotide Processing
2026-09-24
Meng et al. resolve structural and functional questions about the ASCH-domain protein EcYqfB, showing that it hydrolyzes free N4-acetylcytidine (ac4C) nucleoside rather than removing ac4C from RNA. Structures of EcYqfB and related proteins clarify how distinct binding pockets and nucleic-acid interactions may shape substrate preferences, while the results caution against inferring RNA demodification from nucleoside activity alone.
-
G007-LK: Tankyrase Inhibition Beyond Wnt
2026-09-24
G007-LK offers a practical way to interrogate tankyrase-dependent protein stability in Wnt/β-catenin and Hippo pathway research. This article connects its use in APC-mutant colorectal cancer models with published hepatocellular carcinoma findings, while outlining experimental controls and translational limits.
-
CDK7 Inhibitor Resistance and the D97N Mutation
2026-09-23
The reference study identifies an acquired CDK7 D97N mutation that drives resistance to non-covalent ATP-competitive inhibitors while preserving sensitivity to covalent CDK7 inhibitors. By combining drug-selection experiments, structural analysis, ligand-affinity measurements, and cross-CDK mutation studies, it establishes a potentially general mechanism of resistance relevant to cancer treatment and molecular monitoring.
-
BAY-826: A Tie-2 Probe for Retinal Neurovascular Biology
2026-09-23
BAY-826 is a potent small molecule inhibitor suited to mechanistic studies of Tie-2-linked angiopoietin signaling. This article explains how to interpret its effects in Müller cell–retinal neuron models without confusing pathway inhibition with direct neuroprotection.
-
miR-196a Drives EAC Aggressiveness via MYC/TERT/NFκB
2026-09-22
García-Castillo and colleagues identify miR-196a as a functional driver of esophageal adenocarcinoma aggressiveness rather than merely a progression marker. Their data connect miR-196a to NFKBIA loss, VCP suppression, c-MYC accumulation, TERT induction, NFκB activation, epithelial-to-mesenchymal transition, and increased motility, providing a mechanistic framework for follow-up cancer research.
-
D-Luciferin Sodium Salt in CAR-M Imaging
2026-09-21
D-Luciferin sodium salt is more than a light-generating reagent: it is a decision point for interpreting luciferase-based measurements in engineered tumor and immune-cell models. This guide connects ATP-dependent bioluminescence assay design with CAR-macrophage research while separating viable-cell signal from true cellular energy metabolism assessment.